News & Views | Published:

Microbiome

Microbiome metabolomics reveals new drivers of human liver steatosis

An integrative multiomics approach in nondiabetic obese women identifies phenylacetate as a microbial metabolite contributing to the accumulation of lipids in the liver and hence to nonalcoholic steatohepatitis.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Postler, T. S. & Ghosh, S. Cell Metab. 26, 110–130 (2017).

  2. 2.

    Claus, S. P. et al. Mol. Syst. Biol 4, 219 (2008).

  3. 3.

    Delzenne, N. M. & Bindels, L. B. Nat. Rev. Gastroenterol. Hepatol. 15, 69–70 (2017).

  4. 4.

    Hoyles, L. Nat. Med. https://doi.org/10.1038/s41591-018-0061-3 (2018).

  5. 5.

    Russell, W. R. et al. Mol. Nutr. Food Res. 57, 523–535 (2013).

  6. 6.

    Koppel, N., Maini Rekdal, V. & Balskus, E. P. Science 356, eaag2770 (2017).

Download references

Author information

Competing interests

The authors declare no competing interests.

Correspondence to Nathalie M. Delzenne.

Rights and permissions

To obtain permission to re-use content from this article visit RightsLink.

About this article

Fig. 1: The gut microbiota contributes to hepatic steatosis.

Marina Spence/Springer Nature